Open AccessEffects of Raloxifene on Cardiovascular Events and Breast Cancer in Postmenopausal Women
Author(s) -
Elizabeth BarrettConnor,
Lori Mosca,
Peter Collins,
Mary Jane Geiger,
Deborah Grady,
Marcel Kornitzer,
Michelle McNabb,
Nanette K. Wenger
Publication year - 2006
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa062462
Subject(s) - medicine , raloxifene , breast cancer , postmenopausal women , oncology , menopause , gynecology , cancer , tamoxifen
The effect of raloxifene, a selective estrogen-receptor modulator, on coronary heart disease (CHD) and breast cancer is not established.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom